abortion

Caracas, September 30, 2026 (venezuelanalysis.com) – Venezuelan feminist organizations protested on Monday to mark International Safe Abortion Day and demand reforms to advance sexual and reproductive rights in the Caribbean nation.

Around 100 activists gathered in Plaza Venezuela, Caracas, to debate the conditions facing working-class women and urge responses from Venezuelan authorities.

“We are here to protest against the absence of inclusive public policies,” Jackeline López, spokesperson for the Clara Zetkin Women’s Movement, told press. “Abortion remains a taboo subject for Venezuelan authorities, whose response is to criminalize it.”

López went on to stress that unsafe abortions mostly plague Venezuelan working-class women.

“The current wages do not allow women access to family planning or contraceptive methods,” she continued. “The right to decide over our bodies is a key public healthcare issue, and leaving it unattended means criminalizing poor women.”

Comunes, Pan y Rosas, and Mujeres en Lucha were some of the other grassroots movements present at the protest. “We have to abort this patriarchal system” was one of the main chants in Monday’s rally. Feminist collectives also organized smaller rallies or public discussion forums in other parts of the country.

Venezuela has one of the most draconian abortion laws in Latin America, with termination of pregnancy only allowed if a doctor determines that the woman’s life is in danger. Women who perform abortions risk six-month to two-year sentences, while doctors who facilitate the procedure face up to three years in prison.

Though the country’s Penal Code was last updated in 2005, articles governing abortion were left unchanged from their original 1915 version.

In recent years, women’s rights organizations have engaged with Venezuelan institutions, including the National Assembly and the Supreme Court, proposing the opening of public debates on sexual and reproductive rights and initiatives to reform the criminal code. However, the projects have not gained traction.

María Alejandra Reyes, an activist from Faldas-R, told Venezuelanalysis that support networks and sources of information for women in need of abortions have “grown organically” in Venezuela despite a lack of institutional progress.

The activist highlighted findings from Faldas-R’s safe abortion hotline, including that more than 50 percent of women who seek information had used some kind of contraceptive method. “This underscores that we are dealing with a public healthcare issue, not just a matter of women being ‘careless’,” she said.

“Also, nearly 40 percent of the women who reach out to us already have kids,” she added. “So they are conscious of what motherhood implies and their decision is driven mostly by the present conditions in Venezuela.”

Reyes warned that the growing influence of conservative religious groups, especially evangelical churches, stands as an obstacle to women’s rights, as well as the country’s “political instability.”

“Women’s rights are never seen as a priority because there is always something urgent going on, whether it’s a [US] economic blockade, or military strikes, or something else,” she explained. “However, we are talking about basic rights for half of the population.”

In recent years, the Venezuelan government, under President Nicolás Maduro and Acting President Delcy Rodríguez, forged close ties with Venezuelan evangelical groups, granting them a public holiday and funding programs. In March, Rodríguez administration officials additionally hosted high-profile international pentecostal pastors, including Trump ally Ramiro Peña.

Edited by Lucas Koerner in Philadelphia, USA.

WASHINGTON — President Trump’s pick to lead the Food and Drug Administration voiced support for the safety of long-established vaccines at a hearing Thursday, even as senators questioned her about the White House’s efforts to upend childhood immunizations.

Dr. Heidi Overton, a physician serving as a White House adviser, has worked on a series of Trump health initiatives, including an executive order last month that called for splitting up and spacing out decades-old childhood vaccinations. Overton stood beside Trump in the Oval Office when he falsely remarked that the combined measles, mumps and rubella, or MMR, vaccine is “quite lethal.”

Senate Health Committee Chairman Sen. Bill Cassidy, a physician from Louisiana, pushed Overton to reject that statement and affirm the safety of FDA-approved vaccines.

“Right now every vaccine that is on the market has been determined to be safe and effective,” including the MMR vaccine, Overton said.

Cassidy repeatedly has tried to extract commitments from Trump health nominees to uphold vaccine standards, including from Health Secretary Robert F. Kennedy Jr., only to see the Republican administration push forward with efforts undermining their use.

“Kennedy gave me guarantees, and he did not keep them,” said Cassidy, a Republican. “If the president asks you to do something that goes against those guarantees you give us today, what will you do?”

Overton said she would “follow the statutory requirements” for FDA commissioners and give Trump her best advice.

If confirmed by the Senate, Overton would inherit a raft of other controversial projects at the agency, including a safety review of the nation’s principal abortion drug and new rules that make it easier to sell flavored electronic cigarettes. Both issues were a focus for Republicans and Democrats on the panel, who will vote on Overton’s nomination.

Overton sidesteps past statements on abortion pill

The FDA approved the abortion pill mifepristone in 2000 and repeatedly has affirmed its safety while broadening access, including allowing it to be sent through the mail. But Kennedy ordered an FDA review of the drug’s safety last year, following calls from antiabortion groups and lawmakers favoring abortion restrictions.

While working at the Trump-aligned America First Policy Institute, Overton called the FDA decision to allow mail delivery of mifepristone “dangerous for women,” referring to the practice as “chemical abortion on demand.”

In response to questions from Washington Sen. Patty Murray, Overton sidestepped her personal views on the drug, stating that it “has met the safety and efficacy determinations of the FDA.” Overton said she didn’t want to “prejudge” the FDA’s safety review of the pill.

“The FDA has said this is safe,” responded Murray, a Democrat. “We need someone in FDA to make sure this is done by science.”

Overton’s abortion views could complicate her efforts to win over two moderate Republicans on the panel: Maine Sen. Susan Collins and Alaska Sen. Lisa Murkowski. Both have bucked their party on the issue, supporting federal access to abortion. Collins is locked in a tight reelection race in which abortion access is a central issue.

But Collins focused her questions Thursday on a different issue: recent FDA decisions allowing new flavored e-cigarettes onto the market. Under previous administrations, including Trump’s first term, the agency had restricted sweet flavors that appeal to kids.

Overton pointed out that approval of the fruit-flavored products had the backing of FDA scientists, who determined the products met the standard of “appropriate for the protection of public health,” by helping adult smokers quit cigarettes.

“They believed that standard was met because so many adult smokers are using flavors preferentially,” Overton said.

To become commissioner, Overton will need a majority of votes from the 21-member health committee, followed by a positive vote from the full Senate.

Under the current administration, leading the agency has involved balancing Trump’s demands for slashing regulations — such as those for vaping products — alongside Kennedy’s interests in scrutinizing vaccines, drugs and food ingredients.

The previous FDA head faced numerous challenges before quitting

Those challenges dogged the tenure of the previous FDA head, Dr. Marty Makary, who resigned in May. Makary’s time at the agency was defined by scientific disputes, leadership changes and a string of media stories detailing low morale and internal dysfunction among staffers. The FDA has lost about 20% of its employees to layoffs, buyouts, retirements or resignations since Trump took office.

Overton studied under Makary at Johns Hopkins University, where she received a doctoral degree in clinical research after earning her medical degree at the University of New Mexico.

Like Makary, Overton has no experience running a large bureaucracy, a critical skill for steering the FDA’s 16,000 staffers spread across numerous U.S. and international locations.

In financial disclosure forms, Overton reported no investments in healthcare or food companies. That’s a stark contrast to Makary and other recent FDA nominees who have had to divest investments or cut other financial ties with companies regulated by the FDA.

Overton reported $50,000 to $100,000 in student loans.

Perrone writes for the Associated Press.

Sept. 22, 2026 3:42 PM PT

WASHINGTON — The U.S. Supreme Court on Tuesday declined to intervene in a custody dispute over a 5-week-old child who was born in Texas after a surrogate refused a California couple’s wishes to have an abortion.

Justice Elena Kagan denied the request from McKenna West, who was seeking conservatorship over a baby boy she gave birth to in Dallas.

The brief order did not detail the legal reasoning, as is typical in emergency appeals. The decision came from Kagan because she handles appeals of cases out of California.

West had previously been rejected by other courts in her efforts to have a say in the treatment of the child, who was born with a life-threatening heart condition. She gave birth to the boy in Dallas, where most abortions are banned, after she refused the couple’s wishes to end the pregnancy.

West had asked the Supreme Court to halt a California court order that recognizes Omar Ahmed and Nausheen Gilkar as the parents of the child whom she calls Gabriel and they call Rumi.

Lawyers for the couple had urged the court to reject the request, questioning what an intervention would do for medical decision-making at an already chaotic time. They also accused West of overstating the prognosis for children born with the heart condition.

“Such chaos would be devastating for Respondents and, most importantly, their child,” the couple told the court.

The legal battle over surrogacy and abortion has attracted the attention and support of Republican officeholders and anti-abortion groups. West has said she believes the couple will not provide life-saving care, citing their request for an abortion at 23 weeks. Gilkar and Ahmed have denied those claims.

The boy was born Aug. 12 with hypoplastic left heart syndrome, a life-threatening condition that prevents normal blood flow to the organ. He underwent surgery soon after he was born. The couple’s attorney said in August that the newborn had been in critical condition and appeared to be “suffering from potential complications.”

Without treatment, children affected by the heart defect can die within days or weeks. Surgical repairs are not necessarily cures, and additional surgeries or heart transplants may be needed, according to the CDC.

Wilder and Whitehurst write for the Associated Press.